atrium medical corporation advanta™ v12 ptfe stent graft system
getinge south east asia pte. ltd. - cardiovascular - advanta™ v12 ptfe stent graft system are indicated for restoring and improving the patency of the iliac artery.
advanta v12 ptfe stent graft system - iliofemoral artery endovascular stent-graft
getinge australia pty ltd - 43526 - iliofemoral artery endovascular stent-graft - the device is a balloon-expandable stent, made of 316l stainless steel and encapsulated with expanded ptfe. the delivery system comprises an over-the-wire catheter with a non-compliant balloon. the delivery system is compatible with a 0.035? guidewire and has a useable length of 80cm or 120cm. two radiopaque marker bands indicate the dilating section of the balloon and aid in stent positioning during fluoroscopy. the atrium advanta v12 ptfe stent graft system is indicated for restoring and improving the patency of the iliac artery
praluent alirocumab (rch) 300 mg/2 ml solution for injection pre-filled pen
sanofi-aventis australia pty ltd - alirocumab, quantity: 300 mg - injection, solution - excipient ingredients: histidine; sucrose; polysorbate 20; water for injections - primary hypercholesterolaemia praluent is indicated as an adjunct to diet and exercise to reduce ldl-c in adults with primary (heterozygous familial or non-familial) hypercholesterolaemia in patients with moderate to very high cardiovascular risk: - in combination with a statin, or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with maximum tolerated dose of a statin, - alone or in combination with other lipid lowering therapies in patients who are statin intolerant or for whom a statin is contraindicated who are unable to reach ldl-c goals.,prevention of cardiovascular events praluent is indicated to reduce the risk of cardiovascular events (myocardial infarction, stroke, unstable angina requiring hospitalisation) in adults with established cardiovascular disease, in combination with optimally dosed statins and/or other lipid-lowering therapies (see section 5.1 pharmacodynamic properties, clinical trials).
lifetime octa-polycosanol v12 sugar cane 12mg
lifetime pharmaceuticals - sugar cane wax alcohols, quantity: 12 mg - tablet, uncoated - excipient ingredients: magnesium stearate; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; croscarmellose sodium; brilliant blue fcf; colloidal anhydrous silica - sugar cane wax alcohols are obtained from the stems and leaves of sugar cane. they may assist in maintaining & managing normal healthy cholesterol levels.
oruvail sr ketoprofen 200mg capsule blister pack
sanofi-aventis australia pty ltd - ketoprofen, quantity: 185.8 mg - capsule, modified release - excipient ingredients: erythrosine; sodium lauryl sulfate; purified talc; shellac; titanium dioxide; gelatin; ethylcellulose; colloidal anhydrous silica; indigo carmine aluminium lake; butan-1-ol; industrial methylated spirit; purified water; sulfuric acid; ammonia; maize starch; sucrose - rheumatoid arthritis; osteoarthritis.
vitamore arterol v12 tablets
nature's care manufacture pty limited - sugar cane wax alcohols -
nature's queen octa-polycosanol v12 sugar cane 12mg
proudex australia pty ltd - sugar cane wax alcohols -
nature's care arterol v12
nature's care manufacture pty limited - sugar cane wax alcohols -
degree for men absolute protection v12 antiperspirant and deodorant- aluminum zirconium tetrachlorohydrex gly stick
conopco inc. d/b/a unilever - aluminum zirconium tetrachlorohydrex gly (unii: 8o386558je) (aluminum cation - unii:3xhb1d032b) - aluminum zirconium tetrachlorohydrex gly 18.5 g in 100 g - do not use on broken skin stop use if rash or irritation occurs
degree v12 antiperspirant and deodorant- aluminum zirconium tetrachlorohydrex gly stick
conopco inc. d/b/a unilever - aluminum zirconium tetrachlorohydrex gly (unii: 8o386558je) (aluminum cation - unii:3xhb1d032b) -